Dec. 17 (UPI) -- A Food and Drug Administration advisory committee voted Thursday to recommend the COVID-19 vaccine developed by Moderna for emergency use authorization.
The Vaccines and Related Biological Products Advisory Committee voted 20-0, with one abstention, to advise FDA Commissioner Dr. Stephen Hahn to issue an EUA for the vaccine. The vote came after a roughly 8-hour meeting of the committee to discuss the efficacy and potential side effects of the vaccine.